Research

Rapid evidence reviews, data analysis and thought-provoking writing on the coronavirus pandemic, updated regularly by our team with international collaborators. Our reviews have informed international policy and media reporting.

Since 2014, the CEBM have been conducting research about the effects of neuraminidase inhibitors for treating symptoms of influenza. These activities have led to important changes in health policy and clinical practice.

Jamie Hartmann-Boyce leads the Cochrane living systematic review of electronic cigarettes for smoking cessation, to evaluate the safety and effect of using ECs to help people who smoke achieve long‐term smoking abstinence.

One of the principal uncertainties regards the means by which COVID-19 is transmitted. Our open evidence approach analyses the transmission dynamics of COVID-19 and includes evidence searches, research summaries and more.

In 2014 Professor Carl Heneghan joined an undercover investigation to expose how the regulation of medical devices is so lax that mesh packaging for fruit could be approved as a medical device to be implanted in people’s bodies.

Oral hormone pregnancy tests were given to over a million women in 20th Century, until they were withdrawn over safety concerns. Our systematic review uncovers a link between Primodos and congenital malformation.

CEBM researchers are leading research to optimise the use of anticoagulants. The work includes a suite of systematic reviews, several of which have influenced national and international health policy and clinical guidelines.